Authors
Affiliations:
Tyra Biosciences, Inc.
Carlsbad, CA, USA
Steele is an attorney in the Columbus, Ohio, office of Reminger Co, LPA. He specializes in malpractice defense and insurance litigation.
Anderson is an assistant professor of urology at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York.
Myre is a medical oncologist with Elmhurst Hematology Oncology Group in Elmhurst, Illinois.
Harris is a urologic oncologist with UroPartners LLC in Chicago, Illinois.
Advertisement
Advertisement
Trending on Urology Times
1
How PSMA-PET shapes staging and recurrence workup in prostate cancer
2
European Commission approves perioperative pembrolizumab plus enfortumab vedotin for MIBC
3
FDA accepts new drug application for UGN-103 in recurrent LG-IR-NMIBC
4
Engy Habashy, MD, on the role of androgens in GSM management
5

